Dominant mutations in GARS, encoding the ubiquitous enzyme glycyl-tRNA synthetase (GlyRS), cause peripheral nerve degeneration and Charcot-Marie-Tooth disease type 2D (CMT2D). Here, GARS1 is linked to Autosomal dominant Charcot-Marie-Tooth disease type 2D.